- Home
- NBIX vs FSLR Comparison
NBIX vs FSLR Comparison
Compare NBIX & FSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- FSLR
- Stock Information
- Founded
- NBIX 1992
- FSLR 1999
- Country
- NBIX United States
- FSLR United States
- Employees
- NBIX N/A
- FSLR N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- FSLR Semiconductors
- Sector
- NBIX Health Care
- FSLR Technology
- Exchange
- NBIX Nasdaq
- FSLR Nasdaq
- Market Cap
- NBIX 12.2B
- FSLR 13.1B
- IPO Year
- NBIX 1996
- FSLR 2006
- Fundamental
- Price
- NBIX $127.70
- FSLR $163.63
- Analyst Decision
- NBIX Strong Buy
- FSLR Strong Buy
- Analyst Count
- NBIX 20
- FSLR 30
- Target Price
- NBIX $163.20
- FSLR $234.50
- AVG Volume (30 Days)
- NBIX 857.9K
- FSLR 4.9M
- Earning Date
- NBIX 07-31-2025
- FSLR 07-29-2025
- Dividend Yield
- NBIX N/A
- FSLR N/A
- EPS Growth
- NBIX N/A
- FSLR 23.43
- EPS
- NBIX 2.96
- FSLR 11.77
- Revenue
- NBIX $2,412,600,000.00
- FSLR $4,256,749,000.00
- Revenue This Year
- NBIX $16.29
- FSLR $22.39
- Revenue Next Year
- NBIX $15.08
- FSLR $21.13
- P/E Ratio
- NBIX $42.60
- FSLR $14.06
- Revenue Growth
- NBIX 21.73
- FSLR 19.42
- 52 Week Low
- NBIX $84.23
- FSLR $116.56
- 52 Week High
- NBIX $157.98
- FSLR $262.72
- Technical
- Relative Strength Index (RSI)
- NBIX 61.87
- FSLR 57.93
- Support Level
- NBIX $125.02
- FSLR $149.54
- Resistance Level
- NBIX $128.66
- FSLR $158.99
- Average True Range (ATR)
- NBIX 2.62
- FSLR 8.03
- MACD
- NBIX -0.36
- FSLR 0.39
- Stochastic Oscillator
- NBIX 84.17
- FSLR 72.92
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About FSLR First Solar Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.